NEW YORK (GenomeWeb) – Qiagen and CareDx announced today that they have signed a deal to combine a Qiagen DNA analysis platform with CareDx's HLA typing kits and interpretation software, and market the combined product to transplant labs.

The firms will put together Qiagen's QIAxcel Advanced automated capillary electrophoresis system and CareDx's Olerup SSP kits and Score software as an additional option for HLA typing processing and data entry for transplant labs.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.